Radiochromic films are mainly used for two-dimensional dose verification in photon,
electron, and proton therapy treatments. Moreover, the radiochromic film types available …

Abstract 155 Tb [t 1/2= 5.32 d, E γ= 87 keV (32%); 105 keV (25%)(IAEA, 2021) is a novel
promising radionuclide for theranostic applications in nuclear medicine. Its physical …

The availability of novel radionuclides plays a fundamental role in the development of
personalized nuclear medicine. In particular, there is growing interest in pairs formed by two …

Novel medical radioisotopes for both diagnostic and therapy are essential for the future
development of personalized nuclear medicine. Among them, radiometals can be used to …

Radiometals play a fundamental role in the development of personalized nuclear medicine.
In particular, copper radioisotopes are attracting increasing interest since they offer a varying …

The availability of novel medical radionuclides is a key point in the development of
personalised nuclear medicine. In particular, copper radioisotopes are attracting …

The future development of personalized nuclear medicine relies on the availability of novel
medical radionuclides. In particular, radiometals are attracting considerable interest since …

The production of medical radioisotopes for theranostics is essential for nuclear medicine
developments. A research program is ongoing at the 18 MeV Bern medical cyclotron, where …

The characterization of particle accelerator induced neutron fields is challenging but
fundamental for research and industrial activities, including radiation protection, neutron …

Abstract 44 Sc is a β+-emitter which has been extensively studied for nuclear medicine
applications. Its promising decay characteristics [t 1/2= 3.97 h, E β+= 632 keV (94.3%), E γ …